Sign in

Angela Drake

Director at SSD
Board

About Angela Drake

Angela Drake, age 53, was appointed as an independent director of Simpson Manufacturing Co., Inc. effective January 1, 2025. She is Executive Vice President & Chief Financial Officer of The Toro Company (since March 2023), with prior leadership roles spanning finance, construction, and M&A integration at Toro (2019–2023), and served as CFO of Charles Machine Works (2011–2019). She serves on Simpson’s Audit & Finance and Compensation & Leadership Development Committees and has been designated by the Board as an “audit committee financial expert.” She also serves on the board of First Bank & Trust Company .

Past Roles

OrganizationRoleTenureCommittees/Impact
The Toro CompanyEVP & Chief Financial OfficerMar 2023–PresentFinance leadership in a global manufacturing environment
The Toro CompanyVP Finance; VP Construction; Sr. Managing Director, Integration Co‑Lead2019–2023Integration leadership following acquisitions; finance and operating oversight
Charles Machine WorksChief Financial Officer2011–2019CFO of privately held manufacturer acquired by Toro in 2019

External Roles

OrganizationRoleTenureCommittees/Impact
The Toro Company (NYSE: TTC)Executive Vice President & CFOMar 2023–PresentPublic-company CFO; financial reporting, capital allocation
First Bank & Trust CompanyDirectorNot disclosedCommunity bank board service

Board Governance

  • Independence: The Board affirmed Ms. Drake is independent under NYSE standards; none of the independent directors (including Ms. Drake) had relationships deemed material. No familial relationships with executives or significant stockholders were disclosed .
  • Committees and role:
    • Audit & Finance Committee – Member; Board-designated “audit committee financial expert” .
    • Compensation & Leadership Development Committee – Member .
    • Not a committee chair as of Jan 1, 2025 or under the May 6, 2025 composition .
  • Board activity and executive sessions: In 2024 the Board held 6 meetings; committees held 33 (Audit 11; Compensation 10; Nominating 8; Corporate Strategy 4). Independent directors regularly met in executive sessions; 100% of then-current directors attended the 2024 Annual Meeting. Note: Ms. Drake joined the Board in 2025, so no 2024 attendance metric applies to her .
  • Anti‑hedging/anti‑pledging: Directors, officers and employees are prohibited from hedging and pledging company stock .
  • Investor confidence context: Say-on-pay support exceeded 99.5% at the 2024 Annual Meeting .

Fixed Compensation

Non-employee director cash fees (2024 program; paid quarterly or upon appointment):

Cash ElementAmount (USD)
Annual Board Member Retainer$75,000
Audit & Finance Committee – Member$10,000
Compensation & Leadership Development Committee – Member$10,000
Nominating & CSR Committee – Member$10,000
Corporate Strategy & Acquisitions Committee – Member$7,000
Committee Chair Retainers (each standing committee)$10,000 (each)
Additional Retainer – Chair of the Board$66,500

2024 director compensation (context): Ms. Drake joined in 2025 and had no 2024 director compensation (shown as “—” in the 2024 table) .

Performance Compensation

  • Equity grants to non-employee directors are vested share awards with a target value of approximately $125,000 annually; the number of shares is based on a 60‑day average price prior to the grant date. The Board Chair receives an additional vested share grant of approximately $38,500. 2024 awards were valued at the NYSE closing price of $173.89 on April 30, 2024 .
  • As of December 31, 2024, non-employee directors held no unvested stock awards or outstanding options (all awards to directors are vested shares, not options) .
  • No performance metrics are tied to director compensation (director equity is not performance-based) .
Director Equity Program FeatureDetail
Annual equity (non-employee directors)Vested shares ≈ $125,000 value
Chair additional equityVested shares ≈ $38,500 value
2024 valuation reference$173.89/share (close on 4/30/2024)
Unvested/option awards outstanding (12/31/2024)None for non-employee directors

Other Directorships & Interlocks

CategoryDetail
Other current public company boardsNone (per director nominees table)
Potential interlocksNone disclosed in proxy; no material relationships identified by Board in independence review
Related-party transactionsCompany policy requires review/approval; none required disclosure in the 2025 proxy

Expertise & Qualifications

  • Financial and accounting expertise in manufacturing; designated as an “audit committee financial expert” by the Board .
  • Strategic planning, people operations, business management, M&A integration experience (Toro; Charles Machine Works) .
  • Board-level independence and service on key oversight committees (Audit & Finance; Compensation & Leadership Development) .

Equity Ownership

MetricValue
Shares beneficially owned (as of Jan 31, 2025)230 shares
Ownership as % of shares outstanding≈0.0005% (230 / 41,974,436 shares)
Vested vs. unvestedNon-employee directors held no unvested awards as of 12/31/2024
Options (exercisable/unexercisable)None outstanding for non-employee directors (12/31/2024)
Shares pledged as collateralProhibited by Company policy
Hedging of company stockProhibited by Company policy
Stock ownership guidelines (Board)Guidelines are in place for the Board (no multiple disclosed in proxy)

Governance Assessment

  • Strengths and positive signals
    • Independent director with deep CFO and manufacturing finance experience; designated audit committee financial expert—enhances audit oversight quality .
    • Service on Audit & Finance and Compensation & Leadership Development aligns with her skill set and improves board effectiveness in financial reporting and pay governance .
    • Anti‑hedging and anti‑pledging policies and Board/NEO ownership guidelines support alignment with shareholders .
    • No related-party transactions requiring disclosure; high Say‑on‑Pay support (99.5%) indicates strong investor confidence in governance and pay practices .
  • Watch items / potential risks
    • New appointment (effective 2025) means no personal attendance history in 2024; monitoring meeting participation in 2025 will be important .
    • Significant external executive role (CFO of Toro) raises typical time‑commitment considerations; Board independence review found no material relationships, and RPT policy provides guardrails .

References:

  • Director biography, age, tenure, committees, and external roles .
  • Committee rosters and financial expert designation .
  • Independence determination .
  • Meeting cadence and executive sessions .
  • Director cash fees and equity program; 2024 valuation .
  • Beneficial ownership (director-level) and shares outstanding .
  • Anti‑hedging/pledging and ownership guidelines .
  • Say‑on‑Pay support .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%